We are live on
!
Find out more
Vontobel Holding Portfolio holdings
AUM
$29.1B
1-Year Est. Return
22.79%
This Fund
S&P 500
This Quarter
Est. Return
+10.33%
1 Year Est. Return
+22.79%
3 Year Est. Return
+78.52%
5 Year Est. Return
+85.53%
10 Year Est. Return
–
AUM
$12.5B
AUM Growth
+$568M
(+4.8%)
Cap. Flow
-$388M
Cap. Flow
% of AUM
-3.1%
Top 10 Holdings %
Top 10 Hldgs %
25.72%
Holding
1,185
New
85
Increased
350
Reduced
548
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$147M |
| 2 |
Logitech
LOGI
|
+$130M |
| 3 |
Cadence Design Systems
CDNS
|
+$51.5M |
| 4 |
Amazon
AMZN
|
+$46.3M |
| 5 |
ServiceNow
NOW
|
+$42.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$242M |
| 2 |
Pinduoduo
PDD
|
+$95.8M |
| 3 |
Applied Materials
AMAT
|
+$73.5M |
| 4 |
Synopsys
SNPS
|
+$56.9M |
| 5 |
Equinix
EQIX
|
+$48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.25% |
| 2 | Healthcare | 12.13% |
| 3 | Financials | 11.44% |
| 4 | Industrials | 11.13% |
| 5 | Consumer Discretionary | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVPH
1051
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $52.9K | ﹤0.01% |
700
| – | – |
|
1052
Upland Software
UPLD
$13.3M
| $52.5K | ﹤0.01% |
1,700
| – | – |
|
1053
Quantum Computing Inc
QUBT
$1.65B
| $50.5K | ﹤0.01% |
+51,000
| New | +$45.9K |
|
1054
Applied Digital
APLD
$6.68B
| $48.1K | ﹤0.01% |
11,235
-5,265
| -32% | -$26.6K |
|
1055
CEL-SCI Corp
CVM
$19.9M
| $47.8K | ﹤0.01% |
833
| – | – |
|
1056
Clean Energy Fuels
CLNE
$416M
| $47.1K | ﹤0.01% |
17,561
-3,508
| -17% | -$10.5K |
|
1057
Redwire
RDW
$1.86B
| $46.6K | ﹤0.01% |
+10,605
| New | +$33.7K |
|
1058
SSR Mining
SSRM
$5.19B
| $44.6K | ﹤0.01% |
10,023
-447
| -4% | -$3.12K |
|
1059
Rigel Pharmaceuticals
RIGL
$723M
| $44.4K | ﹤0.01% |
3,000
| – | – |
|
|
SGMO
1060
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $39.2K | ﹤0.01% |
58,560
+18,000
| +44% | +$13.1K |
|
|
ADAP
1061
DELISTED
Adaptimmune Therapeutics
ADAP
| $36.3K | ﹤0.01% |
+23,000
| New | +$27.8K |
|
|
WIMI
1062
WiMi Hologram Cloud
WIMI
$22.1M
| $34K | ﹤0.01% |
3,741
-2,669
| -42% | -$24.4K |
|
1063
Planet Labs
PL
$6.94B
| $32K | ﹤0.01% |
12,537
-38,956
| -76% | -$88K |
|
|
CAN
1064
Canaan Creative
CAN
$172M
| $31.9K | ﹤0.01% |
+21,008
| New | +$35.6K |
|
|
BZUN
1065
Baozun
BZUN
$179M
| $30.8K | ﹤0.01% |
13,397
-518
| -4% | -$1.24K |
|
|
CVAC
1066
DELISTED
CureVac
CVAC
| $30.6K | ﹤0.01% |
10,098
-486
| -5% | -$1.71K |
|
|
DADA
1067
DELISTED
Dada Nexus
DADA
| $27.7K | ﹤0.01% |
13,499
-523
| -4% | -$1.12K |
|
|
DMTK
1068
DELISTED
DermTech, Inc. Common Stock
DMTK
| $26K | ﹤0.01% |
37,000
| – | – |
|
|
QUCY
1069
Quantum Cyber N.V.
QUCY
$24.1M
| $25.8K | ﹤0.01% |
625
+275
| +79% | +$11.3K |
|
1070
Aclaris Therapeutics
ACRS
$715M
| $24.8K | ﹤0.01% |
20,000
-10,268
| -34% | -$12.2K |
|
|
ACHL
1071
DELISTED
Achilles Therapeutics
ACHL
| $23.8K | ﹤0.01% |
+19,000
| New | +$20.5K |
|
|
ITRM
1072
DELISTED
Iterum Therapeutics
ITRM
| $23.1K | ﹤0.01% |
+15,000
| New | +$24.4K |
|
1073
ProQR Therapeutics
PRQR
$244M
| $22.7K | ﹤0.01% |
10,000
| – | – |
|
|
TBIO
1074
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $22.3K | ﹤0.01% |
2,778
| – | – |
|
1075
CytomX Therapeutics
CTMX
$690M
| $21.8K | ﹤0.01% |
10,000
| – | – |
|
Similar funds
Vontobel Holding's Q1 2024 Portfolio in Review
As of Q1 2024, Vontobel Holding held 1,185 positions worth $12.5B, up 4.8% from $11.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Vontobel Holding withdrew a net $388M in Q1 2024, closing 100 positions and reducing 548 holdings. Its most notable exit was Edgewise Therapeutics, an estimated $3.59M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Vontobel Holding opened a new position in Flutter Entertainment worth $7.91M.
- Vontobel Holding's largest Q1 2024 buy was Flutter Entertainment: 39,652 shares worth $7.91M.
- Vontobel Holding added most to UBS Group in Q1 2024, an estimated $147M increase.
- Vontobel Holding's biggest Q1 2024 reduction was TSMC, cutting an estimated $242M.
- Vontobel Holding fully exited Edgewise Therapeutics in Q1 2024, selling an estimated $3.59M.
- Vontobel Holding's ten largest holdings make up 26% of its $12.5B portfolio in Q1 2024.
- Vontobel Holding opened 85 new positions and closed 100 in Q1 2024.
- Vontobel Holding's portfolio value rose 4.8% quarter-over-quarter to $12.5B.
Based on Vontobel Holding's 13F filing for Q1 2024, filed 10 May 2024.